Results for this period
Interim period (second quarter)1 March 2026 to 31 August 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Orders and sales of walking aids remained firm, while expanding replacement and additional demand and progress in the adoption of new products contributed to revenue. Profit in the manufacturing and sales business increased due to improvements in production efficiency and the effects of cost-reduction measures. Meanwhile, the care services business posted lower revenue due in part to the impact of a change in the fiscal year-end of a consolidated subsidiary, and the e-commerce business posted lower revenue due in part to the backlash from advertising and sales promotion measures implemented in the same period of the previous year.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2026 to 31 August 2026 |
| Net Sales | ¥3,524 million (YoY +5.5%) |
| Operating profit | ¥556 million (YoY +47.5%) |
| Ordinary income | ¥498 million (YoY +33.0%) |
| Profit attributable to owners of the parent | ¥326 million (YoY +36.6%) |
| Net income per share | ¥78.61 |
| Equity ratio | End of the current fiscal period 66.4 / End of previous period 67.4 |
| Total assets | ¥5,745 million |
| Net assets | ¥3,926 million |
| Cash flows from operating activities | ¥881,349 thousand |
| Cash flows from investing activities | ¥-361,126 thousand |
| Cash flows from financing activities | ¥-79,454 thousand |
| Cash and cash equivalents at end of period | ¥1,838,222 thousand |
| Full-year earnings forecast | Net Sales ¥6,403 million (YoY +0.2%) / Operating profit ¥753 million (YoY +0.7%) / Ordinary income ¥734 million (YoY +10.1%) / Profit attributable to owners of the parent ¥486 million (YoY +13.9%) |
| Annual Dividend Forecast | ¥13 → ¥13（0.0%） |
| Segment revenue | Nursing-care and welfare equipment manufacturing and sales business ¥3,048,531 thousand (YoY +9.0%), Long-term care services business ¥126,664 thousand (YoY -18.0%), EC Business ¥349,360 thousand (YoY -16.2%) |
| Segment profit | Nursing-care and welfare equipment manufacturing and sales business ¥694,384 thousand (YoY +30.5%), Long-term care services business ¥-31,142 thousand, EC Business ¥24,823 thousand (YoY +18.8%) |
| Depreciation and amortization | ¥72,666 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥5,176 thousand / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Newly consolidated: 0 companies; excluded from consolidation: 0 companies (material changes to the scope of consolidation during the period: None) |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No (no target participants specified) |
| Issued Shares at Period-End | 5,032,630 shares |
| Treasury Shares at Period-End | 877,134 shares |
| Factors Behind Changes in Business Performance | Orders and sales of walking aids remained firm, while expanding replacement and additional demand and progress in the adoption of new products contributed to revenue. Profit in the manufacturing and sales business increased due to improvements in production efficiency and the effects of cost-reduction measures. Meanwhile, the care services business posted lower revenue due in part to the impact of a change in the fiscal year-end of a consolidated subsidiary, and the e-commerce business posted lower revenue due in part to the backlash from advertising and sales promotion measures implemented in the same period of the previous year. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Orders and sales of the company’s core product, walking aids, remained firm. Replacement and additional demand, as well as the adoption of new products, also contributed to revenue. On the profit front, improvements in production efficiency and the effects of cost-reduction measures progressed.